Balyasny Asset Management
CVRX icon

Balyasny Asset Management’s CVRx CVRX Stock Holding History

Balyasny Asset Management’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.97M Sell
630,812
-184,131
-23% -$1.35M 0.01% 1285
2025
Q4 		$5.79M Buy
814,943
+118,683
+17% +$1.08M 0.01% 1321
2025
Q3 		$5.62M Buy
696,260
+21,575
+3% +$162K 0.01% 1324
2025
Q2 		$3.97M Buy
674,685
+267,063
+66% +$1.84M 0.01% 1395
2025
Q1 		$4.99M Buy
407,622
+63,457
+18% +$896K 0.01% 1242
2024
Q4 		$4.36M Sell
344,165
-162,233
-32% -$2M 0.01% 1350
2024
Q3 		$4.46M Buy
506,398
+63,284
+14% +$575K 0.01% 1306
2024
Q2 		$5.31M Sell
443,114
-175,416
-28% -$2.02M 0.01% 1140
2024
Q1 		$11.3M Buy
618,530
+211,522
+52% +$5.01M 0.02% 866
2023
Q4 		$12.8M Sell
407,008
-268,012
-40% -$5.03M 0.02% 774
2023
Q3 		$10.2M Sell
675,020
-118,474
-15% -$1.95M 0.02% 838
2023
Q2 		$12.3M Buy
793,494
+113,190
+17% +$1.38M 0.03% 694
2023
Q1 		$6.34M Buy
+680,304
New +$9M 0.02% 981
2021
Q3 		– Sell
-25,000
Closed -$700K – 2020
2021
Q2 		$700K Buy
+25,000
New +$700K ﹤0.01% 1444

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GP
GSK plc London $599M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management's CVRX Position: Q1 2026 in Review

Balyasny Asset Management reduced its CVRx (CVRX) stake by 23% in Q1 2026, selling an estimated $1.35M and leaving 630,812 shares worth $5.97M. The position accounts for 0.01% of the portfolio, ranked #1285.

Balyasny Asset Management first reported a position in CVRX in Q2 2021 and has held it in 14 quarters since. The position peaked at $12.8M in Q4 2023. 99 funds tracked by Wall St. Rank hold CVRX as of Q1 2026.

  • Balyasny Asset Management held 630,812 shares of CVRx worth $5.97M as of Q1 2026.
  • Balyasny Asset Management sold 184,131 CVRx shares in Q1 2026, an estimated $1.35M.
  • CVRx made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1285 holding.
  • Balyasny Asset Management first reported a position in CVRx in Q2 2021 and has held it in 14 quarters since.
  • Balyasny Asset Management's CVRx position peaked at $12.8M in Q4 2023.
  • 99 funds tracked by Wall St. Rank held CVRx as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.